---
input_text: '[Extramedullary relapse of acute myeloid leukemia with pericardial effusion
  after allogeneic hematopoietic stem cell transplantation]. A 62-year-old man presented
  with anemia and neutropenia, and was diagnosed with acute myeloid leukemia with
  myelodysplasia-related changes (AML-MRC). His disease was refractory to treatment,
  but went into remission after a third regimen, venetoclax plus azacitidine (Ven+Aza).
  However, the disease relapsed during treatment for an infection, and he underwent
  allogeneic peripheral blood stem cell transplant while not in remission. He did
  not achieve remission after transplantation, but treatment with azacitidine and
  early discontinuation of immunosuppressants led to remission. However, relapse occurred
  on day250 in the form of pericardial effusion. After drainage, Ven+Aza therapy was
  started again, and the pericardial effusion disappeared rapidly. The patient has
  been continuing the same treatment, and has remained in remission for more than
  15 months. Isolated extramedullary relapse caused by pericardial effusion is rare,
  and this case illustrates that Ven+Aza therapy may be effective.'
raw_completion_output: |-
  primary_disease: acute myeloid leukemia

  medical_actions: diagnosis of acute myeloid leukemia; treatment with venetoclax plus azacitidine (Ven+Aza); allogeneic peripheral blood stem cell transplantation; drainage of pericardial effusion; discontinuation of immunosuppressants

  symptoms: anemia; neutropenia; pericardial effusion

  chemicals: venetoclax; azacitidine

  action_annotation_relationships: diagnosis TREATS acute myeloid leukemia IN acute myeloid leukemia; venetoclax plus azacitidine (Ven+Aza) TREATS acute myeloid leukemia IN acute myeloid leukemia; allogeneic peripheral blood stem cell transplantation TREATS acute myeloid leukemia IN acute myeloid leukemia; drainage of pericardial effusion TREATS pericardial effusion IN acute myeloid leukemia; discontinuation of immunosuppressants PREVENTS relapse IN acute myeloid leukemia
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  discontinuation of immunosuppressants PREVENTS relapse IN acute myeloid leukemia

  ===

extracted_object:
  primary_disease: MONDO:0018874
  medical_actions:
    - diagnosis of acute myeloid leukemia
    - treatment with venetoclax plus azacitidine (Ven+Aza)
    - allogeneic peripheral blood stem cell transplantation
    - drainage of pericardial effusion
    - discontinuation of immunosuppressants
  symptoms:
    - HP:0001903
    - HP:0001875
    - HP:0001698
  chemicals:
    - CHEBI:133021
    - CHEBI:2038
  action_annotation_relationships:
    - subject: diagnosis
      predicate: TREATS
      object: HP:0004808
      qualifier: MONDO:0018874
    - subject: TREATS
      predicate: TREATS
      object: HP:0004808
      qualifier: MONDO:0018874
      subject_extension: venetoclax plus azacitidine
    - subject: allogeneic peripheral blood stem cell transplantation
      predicate: TREATS
      object: HP:0004808
      qualifier: MONDO:0018874
    - subject: drainage of pericardial effusion
      predicate: TREATS
      object: HP:0001698
      qualifier: MONDO:0018874
    - subject: discontinuation of immunosuppressants
      predicate: PREVENTS
      object: relapse
      qualifier: MONDO:0018874
      subject_extension: CHEBI:35705
named_entities:
  - id: MONDO:0018874
    label: Acute myeloid leukemia (AML)
  - id: HP:0001945
    label: Fever
  - id: HP:0012378
    label: Fatigue
  - id: MONDO:0020512
    label: T cell acute lymphoblastic leukemia (T-ALL)
  - id: HP:0006727
    label: T-ALL
  - id: CHEBI:50131
    label: Decitabine
  - id: CHEBI:133021
    label: Venetoclax
  - id: HP:0004808
    label: Acute myeloid leukemia
  - id: HP:0002090
    label: pneumonia
  - id: HP:0100806
    label: sepsis
  - id: CHEBI:71019
    label: Homoharringtonine
  - id: CHEBI:28680
    label: Cytarabine
  - id: HP:0000739
    label: anxiety
  - id: HP:0000716
    label: depression
  - id: CHEBI:190514
    label: dasatinib
  - id: CHEBI:23456
    label: cyclodextrins
  - id: MAXO:0000747
    label: Hematopoietic Stem Cell Transplantation (HSCT)
  - id: MAXO:0000647
    label: Chemotherapy
  - id: HP:0002018
    label: Nausea
  - id: HP:0002094
    label: Dyspnea
  - id: HP:0100785
    label: Insomnia
  - id: HP:0012531
    label: Pain
  - id: HP:0002019
    label: Constipation
  - id: CHEBI:2038
    label: Azacitidine
  - id: CHEBI:197440
    label: Tumor necrosis factor-alpha (TNF-alpha)
  - id: MONDO:0004967
    label: Acute Lymphoblastic Leukemia (ALL)
  - id: CHEBI:8378
    label: Prednisolone
  - id: HP:0000001
    label: Acute Lymphoblastic Leukemia (ALL)
  - id: HP:0001297
    label: Stroke
  - id: HP:0001635
    label: Heart failure
  - id: HP:0001677
    label: Coronary atherosclerosis
  - id: MONDO:0004992
    label: Cancer
  - id: MAXO:0001479
    label: allogeneic hematopoietic stem cell transplantation (allo-HSCT)
  - id: MONDO:0004947
    label: B-cell acute lymphoblastic leukemia
  - id: MAXO:0000757
    label: infusion
  - id: MAXO:0000602
    label: Hemodialysis
  - id: HP:0003326
    label: Myalgia
  - id: HP:0002039
    label: Anorexia
  - id: HP:0100519
    label: Anuria
  - id: HP:0011037
    label: Decreased urine output
  - id: HP:0001919
    label: Acute kidney injury
  - id: CHEBI:18332
    label: Levothyroxine
  - id: MONDO:0020511
    label: Acute B-lymphoblastic leukemia (B-ALL)
  - id: HP:0003419
    label: lower back pain
  - id: MONDO:0010651
    label: high-risk myelodysplastic neoplasm (MDS)
  - id: CHEBI:30621
    label: arsenic trioxide
  - id: HP:0002360
    label: sleep disturbances
  - id: MONDO:0017361
    label: Cytokine release syndrome (CRS)
  - id: CHEBI:64360
    label: Tocilizumab
  - id: MONDO:0012883
    label: Acute promyelocytic leukemia (APL)
  - id: MAXO:0000149
    label: Allogeneic hematopoietic cell transplantation (HCT)
  - id: MONDO:0004948
    label: chronic lymphocytic leukemia
  - id: HP:0002014
    label: diarrhea
  - id: CHEBI:63791
    label: lenalidomide
  - id: HP:0005550
    label: chronic lymphocytic leukemia
  - id: MONDO:0003864
    label: Chronic lymphocytic leukemia and small lymphocytic lymphoma (CLL/SLL)
  - id: MAXO:0001298
    label: therapies
  - id: CHEBI:42068
    label: Idarubicin
  - id: HP:0032169
    label: severe infections
  - id: CHEBI:55379
    label: cyclosporine (CsA)
  - id: CHEBI:85010
    label: eltrombopag
  - id: CHEBI:85012
    label: thrombopoietin receptor agonist (TPO-RA)
  - id: MAXO:0001394
    label: oral administration
  - id: MAXO:0001525
    label: intravenous administration
  - id: HP:0002315
    label: Headache
  - id: CHEBI:50858
    label: Corticosteroids
  - id: HP:0100614
    label: myositis
  - id: CHEBI:26708
    label: NA
  - id: CHEBI:76612
    label: Ibrutinib
  - id: CHEBI:167707
    label: Acalabrutinib
  - id: CHEBI:145428
    label: glasdegib
  - id: MONDO:0100096
    label: COVID-19
  - id: MAXO:0010030
    label: bone marrow transplantation
  - id: HP:0001903
    label: anemia
  - id: HP:0001875
    label: neutropenia
  - id: HP:0001698
    label: pericardial effusion
  - id: CHEBI:35705
    label: immunosuppressants
